Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Sell
22
SHWZ Quote, Financials, Valuation and Earnings
Last price:
$0.0000
Seasonality move
:
3.37%
Day range:
$0.0001 - $0.0001
52-week range:
$0.0000 - $0.1300
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.00x
P/B ratio:
0.00x
Volume:
--
Avg. volume:
25.7K
1-year change:
-100%
Market cap:
$100
Revenue:
$172.4M
EPS (TTM):
-$0.81
Analysts' Opinion
-
Consensus RatingMedicine Man Technologies, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $1.4350, Medicine Man Technologies, Inc. has an estimated upside of 143499900% from its current price of $0.0000.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $1.4350 representing 100% downside risk from its current price of $0.0000.
Fair Value
-
According to the consensus of 1 analyst, Medicine Man Technologies, Inc. has 143499900% upside to fair value with a price target of $1.4350 per share.
SHWZ vs. S&P 500
-
Over the past 5 trading days, Medicine Man Technologies, Inc. has underperformed the S&P 500 by -0.1% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Medicine Man Technologies, Inc. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Medicine Man Technologies, Inc. has grown year-over-year revenues for 4 quarters straight. In the most recent quarter Medicine Man Technologies, Inc. reported revenues of $43.2M.
Earnings Growth
-
Medicine Man Technologies, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Medicine Man Technologies, Inc. reported earnings per share of -$0.20.
Enterprise value:
185.8M
EV / Invested capital:
--
Price / LTM sales:
0.00x
EV / EBIT:
93.81x
EV / Revenue:
1.06x
PEG ratio (5yr expected):
0.00x
EV / Free cash flow:
-126.25x
Price / Operating cash flow:
33.15x
Enterprise value / EBITDA:
14.14x
Gross Profit (TTM):
$72M
Return On Assets:
-14.27%
Net Income Margin (TTM):
-28.59%
Return On Equity:
-39.36%
Return On Invested Capital:
-17.94%
Operating Margin:
-6.35%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Income Statement | ||||||
| Revenue | $134.4M | $165.7M | $174.9M | $42.4M | $43.2M | |
| Gross Profit | $39.6M | $66.5M | $54.2M | $14.3M | $19M | |
| Operating Income | $11.7M | $27.6M | -$10.9M | $5M | -$2.7M | |
| EBITDA | $21M | $45.4M | $13.1M | $9.6M | $4.3M | |
| Diluted EPS | -$0.44 | -$0.68 | -$0.91 | -$0.15 | -$0.20 | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $10M | $35.5M | $66.8M | $66.5M | $46.3M | |
| Total Assets | $36M | $183.4M | $318.1M | $369M | $339.6M | |
| Current Liabilities | $6.7M | $13.1M | $28.6M | $49.8M | $85.3M | |
| Total Liabilities | $8.5M | $71.4M | $161.2M | $220.9M | $248.8M | |
| Total Equity | $27.5M | $111.9M | $157M | $148.1M | $90.8M | |
| Total Debt | -- | $54.3M | $136.4M | $181.6M | $198.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $48M | $21.1M | $6.6M | $2.7M | -$108.4K | |
| Cash From Investing | -$116.9M | $3.2M | -$8.1M | -$17.6M | -$616.4K | |
| Cash From Financing | $81.7M | -$38.3M | -$6.1M | -$352.9K | -$160K | |
| Free Cash Flow | $36.5M | $8.6M | -$1.5M | $892.7K | -$724.8K | |
SHWZ
Sector
Market Cap
$100
$27.9M
Price % of 52-Week High
0%
51.04%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.49%
1-Year Price Total Return
-100%
-16.66%
Beta (5-Year)
1.105
0.516
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.0003
200-day SMA
Sell
Level
$0.0089
Bollinger Bands (100)
Sell
Level
-0.0064 - 0.0136
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$0.0001
Relative Strength Index (RSI14)
Sell
Level
48.5073
ADX Line
Neutral
Level
Williams %R
Buy
Level
-100
50-day SMA
Sell
Level
$0.0002
MACD (12, 26)
Sell
Level
0.0000
25-day Aroon Oscillator
Buy
Level
12
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.4322)
Sell
CA Score
(Annual)
Level (-0.6385)
Buy
Beneish M-Score
(Annual)
Level (-3.1041)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (2.1339)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Medicine Man Technologies, Inc. engages in the cultivation, manufacture, distribution, and retail sale of cannabis and cannabis related products. It operates through the following segments: Retail, Wholesale, and Other. The Retail segment includes retail locations for sale of cannabis products. The Wholesale segment manufactures, cultivates, and sells wholesale cannabis and non-cannabis products. The Other segment includes the general corporate operations not categorized as retail or wholesale, and revenue from in-store advertisements and certain vendor operations. The company was founded by Andrew Williams on March 20, 2014 and is headquartered in Denver, CO.
Stock Forecast FAQ
In the current month, SHWZ has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SHWZ average analyst price target in the past 3 months is $1.4350.
-
Where Will Medicine Man Technologies, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Medicine Man Technologies, Inc. share price will rise to $1.4350 per share over the next 12 months.
-
What Do Analysts Say About Medicine Man Technologies, Inc.?
Analysts are divided on their view about Medicine Man Technologies, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Medicine Man Technologies, Inc. is a Sell and believe this share price will drop from its current level to $1.4350.
-
What Is Medicine Man Technologies, Inc.'s Price Target?
The price target for Medicine Man Technologies, Inc. over the next 1-year time period is forecast to be $1.4350 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SHWZ A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Medicine Man Technologies, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of SHWZ?
You can purchase shares of Medicine Man Technologies, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Medicine Man Technologies, Inc. shares.
-
What Is The Medicine Man Technologies, Inc. Share Price Today?
Medicine Man Technologies, Inc. was last trading at $0.0000 per share. This represents the most recent stock quote for Medicine Man Technologies, Inc.. Yesterday, Medicine Man Technologies, Inc. closed at $0.0000 per share.
-
How To Buy Medicine Man Technologies, Inc. Stock Online?
In order to purchase Medicine Man Technologies, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SHWZ Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SHWZ
Sector
P/E ratio
--
23.85x
PEG ratio
0.00x
-0.01x
P/B ratio
0.00x
1.81x
Price / LTM sales
0.00x
1.58x
Growth Metrics
SHWZ
Sector
Revenue growth
8.09%
4.62%
Earnings growth
--
10.5%
Revenue (5-year growth)
85.16%
6.5%
Earnings forecast
-$0.19
-$0.21
Profitability
SHWZ
Sector
Profitability FY 2023
$76M
$3.6M
Return on invested capital
-17.94%
-31.87%
Return on assets
-14.27%
-28.18%
Return on equity
-39.36%
-37.63%
Earnings Date
Last Earnings Date
Apr
1
Next Earnings Date
Dec
21
Estimated Next Earnings Date
Mar
22
Balance Sheet
SHWZ
Sector
Total cash
$12.4M
$26.4M
Short term investments
$456.1K
$25.7M
Total assets
$358.1M
$76.9M
Long term debt
$163.4M
$3.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Berkshire Hathaway Stock Undervalued?
Berkshire Hathaway (NYSE:BRK.A,BRK.B) has undershot the market this year, returning…
Is Oracle Stock Undervalued?
Shares of Oracle (NYSE:ORCL) rocketed higher earlier this year when…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
57
Is GOOG Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 38x
Alerts
Sell
1
LW alert for Dec 20
Lamb Weston Holdings, Inc. [LW] is down 25.96% over the past day.
Buy
54
BMRN alert for Dec 20
BioMarin Pharmaceutical, Inc. [BMRN] is up 17.79% over the past day.
Buy
82
RKLB alert for Dec 20
Rocket Lab Corp. [RKLB] is up 17.72% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
